日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.

STAT3抑制剂WP1066作为肾细胞癌的新型治疗药物

Horiguchi A, Asano T, Kuroda K, Sato A, Asakuma J, Ito K, Hayakawa M, Sumitomo M, Asano T

Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling

中性内肽酶通过阻断黏着斑激酶信号传导来抑制前列腺癌细胞迁移

Sumitomo, M; Shen, R; Walburg, M; Dai, J; Geng, Y; Navarro, D; Boileau, G; Papandreou, C N; Giancotti, F G; Knudsen, B; Nanus, D M